

Insulet
"Makers of Omnipod, the tubeless insulin management system freeing people with diabetes worldwide."
About Insulet
Insulet creates tubeless, wearable insulin management systems that eliminate the burden of multiple daily injections for people with diabetes. The company's flagship product, Omnipod, is a Pod based system that provides continuous insulin delivery without tubes, offering unprecedented freedom and simplicity to over 600,000 customers across 25 countries. Founded in 2000 by a father determined to help his son, Insulet has grown into a global medical device leader with $2.1 billion in revenue. The company combines industry leading research with a deeply personal mission, continuously innovating to reduce the complexity of diabetes management and help people focus on what brings them joy.


3900
Team Members
2000
Founded
Public
Funding
Hybrid
Work Environment
A world where people with diabetes live freely, unburdened by the complexities of insulin management, empowered to pursue their passions and dreams without limitation.
Our mission is to improve the lives of people with diabetes and enable our customers to enjoy simplicity, freedom, and healthier lives through innovative technology.